Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Miscellaneous | 10.87% |
| 5 | Consumer Discretionary | 10.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
United Therapeutics
UTHR
$22.6B
| $3.97M | 0.01% |
36,463
-94,789
| -72% | -$11M |
|
1727
CALL
Booking.com
BKNG
$152B
| $3.96M | 0.01% |
57,500
+47,500
| +475% | +$3.48M |
|
1728
CALL
Charles River Laboratories
CRL
$14.2B
| $3.96M | 0.01% |
+35,000
| New | +$4.38M |
|
|
MDRX
1729
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.96M | 0.01% |
410,921
-1,640,783
| -80% | -$18.3M |
|
1730
Valvoline
VVV
$4.08B
| $3.95M | 0.01% |
203,947
+50,348
| +33% | +$1.01M |
|
1731
Photronics
PLAB
$1.78B
| $3.94M | 0.01% |
407,337
-551,271
| -58% | -$5.3M |
|
|
PETX
1732
DELISTED
Aratana Therapeutics, Inc.
PETX
| $3.94M | 0.01% |
642,923
+346,243
| +117% | +$2.11M |
|
1733
Kulicke & Soffa
KLIC
$4.43B
| $3.93M | 0.01% |
193,754
-305,821
| -61% | -$6.34M |
|
|
CHMI
1734
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $3.92M | 0.01% |
223,336
+39,682
| +22% | +$725K |
|
1735
TIM SA
TIMB
$8.44B
| $3.92M | 0.01% |
255,284
-271,658
| -52% | -$4.17M |
|
1736
Cogent Communications
CCOI
$495M
| $3.9M | 0.01% |
+86,324
| New | +$4.27M |
|
1737
PUT
Analog Devices
ADI
$181B
| $3.9M | 0.01% |
45,400
+24,800
| +120% | +$2.15M |
|
1738
Linde
LIN
$224B
| $3.89M | 0.01% |
+24,949
| New | +$3.94M |
|
|
MFA
1739
MFA Financial
MFA
$896M
| $3.89M | 0.01% |
145,654
-1,717,314
| -92% | -$48.2M |
|
1740
OFG Bancorp
OFG
$2.2B
| $3.89M | 0.01% |
236,283
+164,182
| +228% | +$2.76M |
|
1741
Telecom Argentina
TEO
$5.61B
| $3.88M | 0.01% |
249,304
+112,380
| +82% | +$1.93M |
|
|
DOCU
1742
DocuSign
DOCU
$12.2B
| $3.88M | 0.01% |
+96,713
| New | +$4.06M |
|
|
QIWI
1743
DELISTED
QIWI PLC
QIWI
| $3.87M | 0.01% |
273,559
+183,251
| +203% | +$2.47M |
|
|
DERM
1744
DELISTED
Dermira, Inc.
DERM
| $3.85M | 0.01% |
535,707
-1,841,674
| -77% | -$20.1M |
|
1745
Voyager Therapeutics
VYGR
$213M
| $3.85M | 0.01% |
409,270
-58,346
| -12% | -$749K |
|
|
RFP
1746
DELISTED
Resolute Forest Products Inc.
RFP
| $3.85M | 0.01% |
485,028
-383,576
| -44% | -$4.23M |
|
1747
PUT
eHealth
EHTH
$36.5M
| $3.84M | 0.01% |
+100,000
| New | +$3.36M |
|
|
ATTU
1748
DELISTED
Attunity Ltd
ATTU
| $3.83M | 0.01% |
194,729
-85,981
| -31% | -$1.63M |
|
1749
PUT
Intuitive Surgical
ISRG
$130B
| $3.83M | 0.01% |
+24,000
| New | +$4.07M |
|
1750
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
| $3.83M | 0.01% |
49,116
-3,627
| -7% | -$282K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $2.35B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.